Firebrick Pharma Limited (AU:FRE) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Firebrick Pharma Limited announced the successful passing of all resolutions at its recent Annual General Meeting, including special resolutions on the 7.1A Mandate and an amendment to the constitution. The company, known for its innovative povidone-iodine nasal spray, continues to show progress with its clinical trials and product development. This positive momentum could interest investors looking at potential growth in the pharmaceutical sector.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.